MAPT and Alzheimer disease: By linking systemic and CNS metabolic alterations and by addressing relationships between metabolites and markers of core AD pathology, i.e., amyloid accumulation and tau-related neurodegeneration, this study contributes to the functional understanding of AD pathophysiology.